Large Real-World study tracks safety of anesthesia drug remimazolam
NCT ID NCT05549791
First seen Jan 10, 2026 · Last updated May 25, 2026 · Updated 27 times
Summary
This study looked at the safety of a drug called remimazolam (Rebenin) when used in real-world medical settings for general anesthesia and sedation during bronchoscopy. Researchers observed over 1,200 patients in China to track any side effects. The goal was to gather safety information, not to test if the drug works better than others.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANESTHESIA AND BRONCHOSCOPY SEDATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.